Massivemarkets

MEDP

Medpace Holdings, Inc. Common Stock

Nasdaq · usd

$664.00+10.04 (+1.53%)
As of 9:17:39 AM EDT on Oct 23, 2026 · 15-minute delayed

Medpace Holdings, Inc. Common Stock (MEDP) trades at $664.00 (+1.53%) as of 9:17:39 AM EDT on Oct 23, 2026, +5.96% over the past month. Market cap is $18.29B, with 5.8 days to cover in short interest.

Stock performance

How Medpace Holdings, Inc. Common Stock (MEDP) stock has performed from one day to one year, with its 52-week range.

-0.17%
-$1.10 over 1D
$652.57$652.89$653.21$653.534:05 AM4:20 AM$652.50
1D
-1.29%
1W
+4.03%
1M
+5.96%
YTD
+16.44%
1Y
+8.06%
52-wk range
$373.00 – $684.52

Key statistics

Today's trading snapshot for MEDP: day range, open, previous close, volume and market cap.

Day range
$645.30 – $684.52
Open
$657.11
Prev close
$653.96
Volume
893.95K
Market cap
$18.29B
Shares out
27.91M

Valuation and profitability ratios: P/E, P/S, ROE

Valuation and profitability ratios for Medpace Holdings, Inc. Common Stock: P/E, P/S, P/B, ROE and more.

P/E
37.21
P/S
6.57
P/B
42.15
P/FCF
25.88
ROE
113.3%
ROA
23.9%
Debt/Equity
0.00
Div yield
0.00%

As of Oct 22, 2026

8-K filings

Material corporate events Medpace Holdings, Inc. Common Stock has disclosed to the SEC on Form 8-K.

  • Shareholder returnsOct 21, 2026

    Effective October 20, 2026 ("Effective Date"), the Company's Board of Directors ("Board") terminated the Company's current stock repurchase authorization of the Company's common stock, $0.01 par value ("common stock") which was set to expire on December 31, 2026. As of the Effective Date, this repurchase authorization had $527.0 million remaining.

  • Executive leadershipJun 4, 2026

    Effective June 1, 2026, Medpace Holdings, Inc. (the "Company") appointed Brad W. Hansman, age 43, to the position of Executive Vice President, Operations. In this role, Mr. Hansman shall perform the functions of the Company's principal operating officer along with Susan E. Burwig, the Company's Executive Vice President, Operations.

  • Governance documentsMay 19, 2026

    stockholders approved separate amendments (the "Amendments") to the Restated Certificate of Incorporation of the Company, each as described in the Company's proxy materials related to the 2026 Annual Meeting, (i) to remove supermajority voting requirements and (ii) to remove the limitation on stockholders calling special meetings of stockholders.

  • Executive leadershipApr 22, 2026

    On April 21, 2026, Jesse Geiger notified the Company of his intent to resign as President and that he will retire from the Company effective May 31, 2026. This departure is not the result of any disagreement with the Company regarding its operations, policies, or practices.

  • Debt activityJul 21, 2025

    On July 17, 2025, Medpace Holdings, Inc., a Delaware corporation (the "Company"), through its wholly owned subsidiaries, Medpace, Inc., as borrower, and Medpace IntermediateCo, Inc., as guarantor, entered into Amendment No.9 to Loan Documents ("Amendment No. 9") with PNC Bank, National Association in connection with the Company's unsecured credit facility (the "Loan Documents"). Amendment No. 9 changes the aggregate principal amount that may be borrowed under the facility's line of credit to up to $10 million.

MEDP short interest

How heavily MEDP is shorted: shares short, days to cover and average daily volume.

Days to cover
5.8
Short interest
1.6M
Avg volume
275.44K

As of · reported to FINRA twice monthly.

MEDP news

The latest news and headlines about Medpace Holdings, Inc. Common Stock (MEDP).

Frequently asked questions

What is the Medpace Holdings, Inc. Common Stock (MEDP) stock price today?

Medpace Holdings, Inc. Common Stock (MEDP) is trading at $664.00 (+1.53% on the day) as of 9:17:39 AM EDT on Oct 23, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

What is Medpace Holdings, Inc. Common Stock?

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms.

What is the short interest in MEDP?

As of Sep 30, 2026, MEDP has 1.6M shares short and 5.8 days to cover.

What exchange is MEDP listed on?

Medpace Holdings, Inc. Common Stock (MEDP) trades on Nasdaq in USD, in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH industry.

Build with AI

Build an analysis of MEDP with your agent

Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.

Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a MEDP analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.

Want the most up-to-date, real-time data? Connect to the Massive API and MCP server — the source behind every number on this page — covering stocks, options, indices, currencies and futures. Docs: https://massive.com/docs/rest. Get a free API key.

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.